Discover 1,424 paid clinical trials in Clearwater, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,424
Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
for
Biliary Tract Cancer
Location: St. Petersburg FL, Fort Myers FL, Jacksonville FL,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06467357
Phase 3, Recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
for
Non-Small Cell Lung Cancer
Location: St. Petersburg FL, North Venice FL, Ocala FL,
Sponsor: Summit Therapeutics
Sex: All
Age: 18+
Code: NCT06767514
Phase 3, Recruiting
A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)
for
Chronic Inducible Urticaria, Cold Urticaria,
Location: St. Petersburg FL, Tampa FL, Miami Lakes FL, Hialeah FL,
Sponsor: Celldex Therapeutics
Sex: All
Age: 18+
Code: NCT07266402
Phase 3, Recruiting
A Study Investigating the Safety of RO7795081 and How the Body Processes RO7795081 in People With Normal or Decreased Kidney Functions
for
Renal Impairment
Location: St. Petersburg FL, Orlando FL, Miami Lakes FL
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18 - 70+
Code: NCT07741604
Phase 1, Recruiting
A Study to Assess the Efficacy and Safety of GIA632 Across a Range of Doses in Participants With Moderate to Severe Cutaneous Lichen Planus
for
Cutaneous Lichen Planus
Location: St. Petersburg FL, Hollywood FL, Miami FL, Macon GA,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07775924
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06)
for
Influenza
Location: St. Petersburg FL, New Port Richey FL, Winter Park FL,
Sponsor: Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Sex: All
Age: 12+
Code: NCT07159763
Phase 3, Recruiting
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
for
Atopic Dermatitis
Location: St. Petersburg FL, Miami FL, Panama City FL,
Sponsor: Pfizer
Sex: All
Age: 12+
Code: NCT07765888
Phase 3, Recruiting
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
for
Metastatic Colorectal Cancer (CRC)
Location: St. Petersburg FL, Ocala FL, Orlando FL,
Sponsor: Summit Therapeutics
Sex: All
Age: 18+
Code: NCT07228832
Phase 3, Recruiting
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
for
Endometrial Cancer
Location: St. Petersburg FL, Tampa FL, Fort Myers FL,
Sponsor: AstraZeneca
Sex: Female
Age: 18+
Code: NCT06989112
Phase 3, Recruiting
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
for
Metabolic Dysfunction Associated Steatohepatitis
Location: St. Petersburg FL, Tampa FL, New Port Richey FL,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06632457
Phase 3, Recruiting
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
for
Ovarian Carcinoma
Location: St. Petersburg FL, Tampa FL, Bradenton FL, Sarasota FL,
Sponsor: NRG Oncology
Sex: Female
Age: 35 - 50
Code: NCT04251052
Recruiting
A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
for
Myasthenia Gravis
Location: St. Petersburg FL, Port Charlotte FL,
Sponsor: argenx
Sex: All
Age: 18+
Code: NCT06298565
Recruiting
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
for
Colorectal Neoplasms
Location: St. Petersburg FL, Orlando FL, Fort Myers FL,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06662786
Phase 3, Recruiting
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
for
Non-small Cell Lung Cancer
Location: St. Petersburg FL, West Palm Beach FL, Tamarac FL,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06561386
Phase 3, Recruiting
A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation
for
Non-Small Cell Lung Cancer
Location: St. Petersburg FL, Fort Myers FL, West Palm Beach FL,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT05789082
Phase 1, Phase 2, Recruiting
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
for
Metastatic HER2-positive Breast Cancer
Location: St. Petersburg FL, Fort Myers FL, Jacksonville FL,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06435429
Phase 3, Recruiting
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
for
Colorectal Neoplasms
Location: St. Petersburg FL, Orlando FL, Fort Myers FL,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06750094
Phase 3, Recruiting
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
for
Ovarian Cancer
Location: St. Petersburg FL, Orlando FL, Gainesville FL,
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT07059845
Phase 2, Recruiting
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
for
Metastatic Colorectal Cancer
Location: St. Petersburg FL, Fort Myers FL, West Palm Beach FL,
Sponsor: EMD Serono Research & Development Institute, Inc.
Sex: All
Age: 18+
Code: NCT07549412
Phase 3, Recruiting
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: St. Petersburg FL, Fort Myers FL, West Palm Beach FL,